Suppr超能文献

基于清除率概念对家兔中甲苯磺丁脲-磺胺相互作用的动力学分析。根据体外血浆蛋白结合和代谢预测种属差异。

Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.

作者信息

Sugita O, Sawada Y, Sugiyama Y, Iga T, Hanano M

出版信息

Drug Metab Dispos. 1984 Jan-Feb;12(1):131-8.

PMID:6141904
Abstract

The interaction between tolbutamide (TB) and sulfonamide (SA) in rabbits was quantitatively investigated by both in vivo and in vitro experiments, and the mechanisms of species difference between rabbits and rats were analyzed by comparing the two total body clearances (CLtot) obtained from in vivo and in vitro studies. The sulfonamides used were sulfaphenazole (SP) and sulfadimethoxine (SDM). In vivo CLtot of TB was changed little by SA in rabbits, which was contrary to the phenomenon seen in rats, i.e. CLtot was markedly decreased by SA in rats (Sugita et al., Biochem. Pharmacol., 30, 3347, 1981). The total body clearance defined as CL in vitro tot.pred was predicted for TB in the presence and absence of SA by the equation: CL in vitro tot.pred congruent to fB CL in vitro int, where fB is the blood-free fraction and CL in vitro int is the hepatic intrinsic clearance of unbound drug obtained from in vitro experiments using liver microsomal fraction. A comparatively good agreement was observed between the two CLtot obtained from in vivo and in vitro data. The analysis in rabbits based on these in vitro experiments showed that the small gross changes of in vivo CLtot induced by SA were due to the compensative changes of two factors, i.e. fB and CL in vitro int which in the presence of SA were approximately 200 and 50% of the control, respectively. However, in rats, the marked decrease of in vivo CLtot induced by SA was explained by the greater degree of the decrease in CL in vitro int than that of the increase in fB.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过体内和体外实验对家兔中甲苯磺丁脲(TB)与磺胺类药物(SA)之间的相互作用进行了定量研究,并通过比较体内和体外研究获得的两种总体清除率(CLtot)分析了家兔和大鼠之间物种差异的机制。所使用的磺胺类药物为磺胺苯吡唑(SP)和磺胺二甲氧嘧啶(SDM)。在家兔中,SA对TB的体内CLtot影响很小,这与在大鼠中观察到的现象相反,即在大鼠中SA会使CLtot显著降低(杉田等人,《生物化学与药理学》,30,3347,1981)。通过以下公式预测了存在和不存在SA时TB的体外总体清除率(定义为CL体外tot.pred):CL体外tot.pred ≈ fB CL体外int,其中fB是无血分数,CL体外int是使用肝微粒体部分通过体外实验获得的未结合药物的肝内在清除率。体内和体外数据获得的两种CLtot之间观察到了较好的一致性。基于这些体外实验对家兔的分析表明,SA引起的体内CLtot的微小总体变化是由于两个因素的补偿性变化,即fB和CL体外int,在存在SA的情况下,它们分别约为对照的200%和50%。然而,在大鼠中,SA引起的体内CLtot的显著降低可以通过CL体外int的降低程度大于fB的增加程度来解释。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验